## ARE: Alexandria Real Estate Equities, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 0.0% below STRENGTH zone (3.0-6.0%); PEG 844.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($44.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office is Investigating Claims on Your Behalf**
- Source: GlobeNewswire | 20251223T164338 | Bearish | Relevance: 100%
- Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors at four companies: Alexandria Real Estate Equities (NYSE: ARE), Inspire Medical Systems (NYSE: INSP), Integer Holdings Corp. (NYSE: ITGR), and Synopsys (NASDAQ: SNPS). The investigations stem from alleged misleading statements or concealed adverse facts that negatively impacted shareholder value. Long-term shareholders of these companies who held shares prior to specific dates are encouraged to contact Grabar Law Office to explore options for corporate reforms and recovery of funds.

**2. SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Reminds Alexandria Real Estate Equities Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 26, 2026**
- Source: Morningstar | 20251223T150740 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and reminds investors that the deadline to seek the role of lead plaintiff in a federal securities class action is January 26, 2026. The lawsuit alleges that Alexandria made false and misleading statements regarding its Long Island City property, leading to a significant stock price drop after reporting disappointing Q3 2025 financial results. Investors who purchased Alexandria securities between January 27, 2025, and October 27, 2025, and suffered losses are encouraged to contact the firm.

**3. ARE STOCK: Alexandria Real Estate Equities, Inc. Impairment Charge Triggers Securities Fraud Class Action - Contact BFA Law by January 26 Court Deadline**
- Source: FOX40 News | 20251223T040808 | Bearish | Relevance: 100%
- Alexandria Real Estate Equities, Inc. (NYSE: ARE) faces a securities fraud class action lawsuit due to a significant stock drop, prompted by a $323.9 million real estate impairment charge and lower-than-expected Q3 2025 results. Investors have until January 26, 2026, to seek appointment as lead plaintiff in the case, which alleges violations of federal securities laws. The lawsuit highlights issues with occupancy rates, leasing activity, and the company's Long Island City property.

**4. Alexandria Real Estate Equities outlook revised to negative by S&P**
- Source: Investing.com | 20251222T221751 | Bearish | Relevance: 100%
- S&P Global Ratings has revised its outlook on Alexandria Real Estate Equities Inc. to negative from stable, citing industry headwinds in the life science real estate sector. The company is facing declining occupancy and cash NOI, leading to a dividend cut and plans for increased asset sales to mitigate financial pressures. S&P expects the company's adjusted debt to EBITDA ratio to rise and fixed charge coverage to decline in 2026.

**5. Alexandria Real Estate Equities outlook revised to negative by S&P**
- Source: Investing.com | 20251222T220810 | Bearish | Relevance: 100%
- S&P Global Ratings revised its outlook on Alexandria Real Estate Equities Inc. to negative from stable, citing significant industry headwinds in the life science real estate sector. The company has experienced declining same-property cash NOI and occupancy rates, leading S&P to project further drops and an increase in its adjusted debt to EBITDA ratio. Despite measures like a dividend cut and increased asset sales, the outlook remains negative due to persistent market challenges.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 7)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Jefferies | $47 | $62 | -24% |
| 2025-12-04 | Citigroup | $52 | $61 | -15% |
| 2025-12-04 | Evercore ISI Gr | $64 | $72 | -11% |
| 2025-12-04 | BMO Capital | $60 | $67 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Jefferies | main | Hold |
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Evercore ISI Gr | main | Outperform |
| 2025-12-04 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.14M) |
| Sells | 16 ($4.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 34.7% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -8% YoY, concerning. Analyst sentiment negative (7 target cuts vs 0 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.3B |
| Beta | 1.33 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.7% to 0.0% (-5.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). MRS_5 (-1.9%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.65x), long-term trend not supportive. MACD histogram positive (0.81), confirming momentum. RSI neutral at 41. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.03% (CS: 70) | Neutral |
| RSI_14 | 41.4 | Neutral |
| MACD Histogram | 0.81 | Bullish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 0.853x | Below |
| vs SMA200 | 0.653x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $48.06
- **Stop Loss:** $44.64 (7.1% risk)
- **Target:** $51.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 175
- **Position Value:** $8,410.50
- **Portfolio %:** 8.41%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*